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Abstract
Eomesodermin (Eomes), a T-bet homologue expressed in activated CD8+T cells was recently proposed to act as a master
regulator of cytotoxic CD8+ T cell effector function and offers an exciting avenue for future exploration. Here, we have
identified and characterized the full-length Atlantic salmon Eomes cDNA (2477 bp). Promoter analysis of the salmon Eomes
showed the presence of important putative transcription binding sites like SP1, FOXO, Oct-1, SMAD, STAT, IRF, and Ets-1.
The basal core region responsible for the promoter activity was located between base 2199 and +59. Quantitative PCR
analysis revealed that the Atlantic salmon Eomes was ubiquitously expressed in all the tissues studied but strongly
expressed in the ovary, spleen, brain, and the head kidney. Moreover, the involvement of Eomes in Atlantic salmon immune
response and its relation with the cytolytic activity was demonstrated by investigating the early time dependent expression
profile of Eomes and CD8a followed by high interferon gamma (IFN-c) and granzyme A expression during challenge with
live Aeromonas salmonicida and Infectious Pancreatic Necrosis (IPN) virus. Therefore, we further analyzed the regulated
expression and function of this transcription factor in spleen lymphocytes. Overexpression of Eomes induced IFN-c, and
granzyme A expression but not perforin expression, whereas small interfering RNA (siRNA) mediated suppression of Eomes
expression led to significantly reduced IFN-c production. Thus, Eomes may be critical in cytolytic gene expression and
function in fish similar to mammals. Furthermore, IFN-a, and mitogens induced Eomes expression. Taken together, this is
the first study on the promoter activity and regulatory role of Eomes in fish.
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Introduction
Transcription factors can have a marked effect on the fate of
a cell by initiation of the gene expression patterns that determine
cellular function. Therefore, a great deal of effort has been
invested in identifying and understanding the individual transcrip-
tion factors that influence key activities.
T-box genes belong to a highly conserved gene family that share
a sequence specific DNA-binding domain of approximately 200
amino acids, called the T-box, that was first identified in the
mouse brachyury or T gene [1] and suggested these genes as putative
transcription factors which are important regulators of several
early developmental processes [2]. Eomesodermin (Eomes) has
been shown to play a key regulatory role in initiating mesoderm
cell fate in most vertebrates [3] and in trophoblast differentiation
in mammals [4]. Important roles of Eomes during early
development have also been reported in zebrafish [5–7]. Two
T-box genes are expressed in cells of the immune system:
Eomesodermin [3] and Tbx-21 or T-bet [8].
Recent studies, however, showed that mammalian Eomes is
likely to complement the actions of T-bet and act as a key
regulatory gene in the development of cell mediated immunity [3].
The Eomes gene is similar to the T-bet gene and is expressed in
activated CD8+ T cells, activated CD300a+ CD4 T cells [9] as
well as in resting and activated NK cells [10], and also in activated
cdT-cells [11]. Eomes has been shown to be involved in the
effector differentiation and activation of CD8+ T cells and
cytolytic functions [3,12], plays a critical role in protective effector
function of cdT-cells and offers an exciting avenue for future
exploration in tumor immunity. Furthermore, recent studies have
also established T-bet and Eomes as key regulators of adaptive
cell-mediated immunity against cancer [13]. Overexpression and
antagonism studies using dominant negative factors have sug-
gested that Eomes and T-bet might have cooperative or redundant
functions in regulating the genes encoding IFN-c and cytolytic
molecules in CD8+ T cells [3]. In addition, overexpression of
Eomes has been shown to drive the expression of IFN-c, perforin
and granzyme B, thereby indicating that these genes are also direct
downstream targets of Eomes [14]. These data suggests that
Eomes has a pivotal role in controlling cytolytic activity of murine
and human CD8 T lymphocytes and also in human cdT-cells.
In lower vertebrates, only zebrafish Eomes has been character-
ized and was found to be involved in zebrafish immune response.
Whether this transcription factor in lower vertebrates, like teleosts
possesses similar immune function in cell-mediated responses, as in
mammals, is not yet known [15]. Towards delineating its function,
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the Atlantic salmon (genomic) Eomes was characterized in terms of
sequence and promoter analysis, tissue expression patterns and
immune response following challenge with the well-known fish
pathogens A. salmonicida and IPN virus.
Although it has been established that Eomes plays a key role in
the regulation of cytolytic activity of human and murine CD8+ T
lymphocytes, its function in immune system of lower vertebrates
remains to be elucidated. Therefore, based on the observations
made in the murine and human system, we hypothesize that
eomesodermin is present and is involved in Atlantic salmon
immune response - particularly to lymphocyte function. Accord-
ingly, we also aimed to identify a bundle of the mediators that




Atlantic salmon weighing 70–100 g were kept at the Aquacul-
ture Research Station (Tromsø, Norway) in circular 200 L tanks
supplied with re-circulating freshwater at an ambient temperature
of approximately 10uC with 12/12 h illumination, and fed
a commercial pellet diet. Prior to treatment or challenge, fish
were anaesthetised in 0.005% benzocaine. Fish were sacrificed
using 0.01% benzocaine prior to collection of different tissues. The
challenged fish were also kept at the same conditions as before
challenge. The experimental protocols used for Atlantic salmon in
this study were reviewed and approved by the Committee on the
Ethics and Animal Welfare of Norway, the National Animal
Research Authority (NARA)/(Norwegian: Forsøksdyrutvalget,
FDU), http://www.fdu.no.
Molecular Cloning and Sequencing of Atlantic Salmon
(As) Eomes cDNA
A partial salmon EST sequence similar to vertebrate eomeso-
dermin was identified based on nucleotide and amino acid
sequence homology to zebrafish Eomes1 sequence in GenBank
using the BLAST programme (http://www.ncbi.nlm.nih.gov/
BLAST). Internal primers were designed from the AsEST
sequence and AsEomes clones were obtained from the cDNA
library obtained from the stimulated spleen tissue and sequenced.
39and 59 RACE were performed using a GeneRacerTM Kit
(Invitrogen, Carlsbad, CA, USA) according to manufacturer’s
instruction. Total RNA (3 mg) isolated from Atlantic salmon
(,80 g) spleen tissue using TRIZOLH Reagent (Invitrogen,) was
used as a template and reverse transcribed using SuperscriptTM III
RT and the GeneRacer Oligo dT primer. Primers used for the 59
or 39 RACE are listed in Table I. PCR products were gel purified
using MinElute Gel Extraction kit (QIAgen, Hilden, Germany)
and cloned in a TOPO vector (Invitrogen). Plasmid DNA from at
least 10 independent clones was purified using QIAprep Spin
Miniprep kit and sequenced. The cDNA sequence and deduced
amino acid sequence of Atlantic salmon Eomes were analyzed
using the BLAST program, the ExPASy Molecular Biology server
(http://us.expasy.org) and Pfam [16]. Amino acid identity and
similarity were done with the Matrix Global Alignment Tool
(MatGAT) program v 2.0 [17] using default parameters. Multiple
amino acid sequence alignments were constructed with ClustalW2
program and further edited using GeneDoc, version 2.7.
Phylogenetic tree was constructed using the neighbour-joining
method using the MEGA v 4.0 program [18]. The topological
stability of the tree was evaluated by 10 000 bootstrap re-
samplings.
Isolation of 59-flanking Region of the AsEomes Gene by
Genome Walking
The 59-flanking region of the Eomes gene was isolated using the
Universal GenomeWalker Kit (Clontech, Palo, Alto, CA, USA).
Four GenomeWalker libraries were constructed according to the
manufacturer’s instructions. For each genome walker experiment
two adjacent reverse primers were designed in the 59 UTR region
of the target gene (Table 1), and used in two PCRs in combination
with the forward adaptor primers AP1 and AP2 (Clontech) for
each library. The resulting PCR products from four different
libraries were cloned in TOPO vector (Invitrogen), sequenced and
analyzed as described above.
In order to verify this new sequence, a forward primer
(AsEomes-F3) was designed within this new sequence and used
with a reverse primer (AsEomes-R3) designed within the
transcribed region of the Eomes gene (Table 1). PCR from the
Atlantic salmon genomic DNA was performed and the products
obtained were cloned and sequenced. Identification of transcrip-
tion factor binding motives was performed with TRANSFACH
(Biobase International) and MatInspector version 6.2 [19].
Construction of Reporter Gene Plasmids
Deletion constructs with successive removal of the 59 region
were generated by PCR using the forward primers AP1,
AsEomesMluIF3, AsEomesMluIF2, and AsEomesMluIF1 having
recognition sequences for restriction endonuclease MluI while the
reverse primer (corresponds to region 59 bases downstream to
TSS) AsEomesBglIIR (Table 1) had an BglII restriction site to
generate the constructs p(2003/+58), p(1061/+58), p(2518/+58),
and p(2199/+58), respectively. Similarly, the same 59 deletion
construct was made in parallel using forward primers having SalI
and reverse with SacII restriction sites (Table I). The promoterless
pMet Luciferase Reporter and pSEAP2-Basic Vectors were used
as reporter plasmids for cloning. Both the PCR products of
different 59 deletion constructs and the basic reporter vectors were
digested with their respective restriction enzymes (New England
BioLab Inc., Ipswich, MA, USA) and ligated (T4 DNA ligase) to
generate the above mentioned constructs for each basic reporter
vector (pMet Luciferase and pSEAP2) in parallel. All plasmid
DNA constructs were isolated using Plasmid Mini Kit (Qiagen) to
have pure quality plasmid for transfection. All plasmid constructs
were verified by restriction map analysis and by DNA sequencing.
Cell Culture, Transfection and Reporter Activity Assay
HeLa cells (ATCC CCL-2) were grown as described elsewhere
[20]. The day before transfection, 26104 cells were seeded per
well of a 96 well plate (Nunc) in 100 ml growth medium. The cells
were co-transfected with 0.3 mg of the different Eomes promoter-
pMetLuc reporter constructs, promoterless pMetLuc Reporter,
and pMetLuc control vector and 0.1 mg of different Eomes
promoter-SEAP Reporter constructs, promoterless pSEAP basic,
and pSEAP2-Control vector (for normalizing transfection efficien-
cy) using Polyfect Transfection Reagent (QIAgen) according to the
manufacturer’s instructions. The plasmid DNA of each construct
was prepared using the Plasmid Mini Kit (QIAgen). 24 h after
transfection, the media were removed and replaced by media with
or without 100 ng/ml A. salmonicida LPS (gift from Tim Bowden
and Ian Bricknell, FRS Marine Laboratory, Scotland) to activate
the signal transduction pathway. After 24 h of incubation with
LPS, the culture medium was collected and analyzed for Metridia
luciferase using Ready-To-GlowTM Secreted Luciferase Reporter
System (Clontech) and SEAP activity using Great EscAPeTM
SEAP Chemiluminescence Detection Kit (Clontech). Then the
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luciferase and SEAP activity were assayed using a plate Lumin-
ometer, Luminoskan Ascent (Thermo Electron Corporation,
Finland). The experiment was carried out in triplicate for each
construct, and the Luciferase activity was normalized to the SEAP
activity.
Tissue Specific Expression of AsEomes
The expression pattern of Eomes in different tissues was
measured by real-time PCR. Total RNA from the tissues of liver
spleen, head kidney, gill, thymus, intestine, heart, skin, brain,
ovary and testis was extracted from Atlantic salmon by the
TRIZOLH method.
Table 1. List of primers and their designated applications.
Primer name Sequence 59-39 Application
AsEomes-F1 CCTGTGGCTCAAGTTTCACCGATTC partial cDNA cloning
AsEomes-F2 CCGACAGCCTCCCCTCGCTCTCA 39 RACE
AsEomes-NF CAGCCCTTCTTCCAGGACCAGTTTG 39 RACE
AsEomes-R1 GGGTGACAAACCAGCGCTGAG partial cDNA cloning
AsEomes-R2 CGGCCAACACGACCTCAACAAATAC 59 RACE
AsEomes-NR CCGCCTGCCCTGTTTAGTGATGATC 59 RACE
AsEomes-PriR GGCTACAACCATCAAGACGCTACACCACTG Genome walking
AsEomes-SecR CTAATGTTGACCTTCTCAGTTGCACCTAC Genome walking
AP1 GTAATACGACTCACTATAGGGC Genome walking
AP2 ACTATAGGGCACGCGTGGT Genome walking
AsEomesF3 CCCAATTACTTTGACATGTTACGGGAAG Promoter check
AsEomesR3 GCTATTATTTGCACTATCTGACGACGAGAG Promoter check
AsEomesMluIF1 CG A CGC GT ATG GTT AGC CAA ATG TCA ATT ATG G SEAP construct
AsEomesMluIF2 CG A CGC GT ATC TCC CAA TTA CTT TGA CAT GTT ACG SEAP construct
AsEomesMluIF3 CGACGCGTGACAGGCTCATTTTCCCATTTAACTC SEAP construct
AsEomesBglIIR GAAGATCTGACGCTACACCACTGCGCCCTGGTATG SEAP construct
AsEomesSalIF1 ACGCGTCGACATG GTT AGC CAA ATG TCA ATT ATG G pMet Luciferase construct
AsEomesSalIF2 ACGCGTCGACATC TCC CAA TTA CTT TGA CAT GTT ACG pMet Luciferase construct
AsEomesSalIF3 ACGCGTCGACCGACAGGCTCATTTTCCCATTTAACTC pMet Luciferase construct
AsEomesSacIIR TCCCCGCGGGCTACACCACTGCGCCCTGGTATG pMet Luciferase construct
M13 F CAGGAAACAGCTATGAC Sequencing
M13 R GTAAAACGACGGCCAG Sequencing
T3 F ATTAACCCTCACTAAAGGGA Sequencing




AsEomes-F ACCTCTCGTCGTCAGATAGTG Real time PCR
AsEomes-R GGACCGGTGAGTCTTTTCTTC Real time PCR
AsPerforin 1-F GTGTGTCCTGCGGGTATTAC Real time PCR
AsPerforin 1-R CCTGGCACTGCATGATACTG Real time PCR
AsIFN-c-F CCACTATAAGATCTCCAAGGAC Real time PCR
AsIFN-c-R CTCCTGAACCTTCCCCTTGAC Real time PCR
AsGrzA-F GGTGTTTCTAGGGGTCCACTC Real time PCR
AsGrzA-R TGCCACAGGGACAGGTAACG Real time PCR
AsT-21-F GGCATAGGTGGCAATCTTTACC Real time PCR
AsT-21-R GTGCCGATCCGCCCTGTC Real time PCR
AsEFa-F CGGCAAGTCCACCACCAC Real time PCR
AsEFa-R GTAGTACCTGCCAGTCTCAAAC Real time PCR
AsEomes/myc/XhoI-F CCG CTC GAG CGG ATG GAA CAA AAA CTC ATC TCA GAA GAG GAT CTG ATG CAG CTG
GAG AAT ATT CTT C
Myc tagged expression
construct
AsEomes/EcoRI-R CCG GAA TTC CGT TAG GGG CTT GCG TAA AAG GCA TAG Expression construct
Note: Restriction endonuclease site are underlined.
doi:10.1371/journal.pone.0055893.t001
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In vivo Infection
Bacterial infection. Atlantic salmon (80–100 g) were in-
jected intraperitoneally (i.p) with a 100 ml suspension of 1.36106
colony forming units of live Aeromonas salmonicida (virulent strain,
LFI 4017, originally isolated from Atlantic salmon infected with
furunculosis) in PBS and the fish controls were injected with PBS.
Sampling of head kidney and spleen was performed at 0 h, 4 h,
24 h, 48 h, and 96 h post injection from six fish per group.
Viral infection. Atlantic salmon parr were challenged in
a cohabitation model by adding 12% of IPN virus shedders to the
total biomass in each tank. The virus shedders were intraperito-
neally injected with 16107 TCID50/fish of a highly virulent IPNV
Norwegian SP strain NVI015 (GenBank accession no.
AY379740). At 4, 7, 14, 21 and 56 days post challenge head
kidney and spleen samples were collected from 6 fish at each time
point.
All organs were rapidly transferred to and kept in RNA-later
(Ambion, Austin, TX, USA) and subsequently processed for RNA
isolation. Total RNA was extracted by TRIZOLH (Invitrogen)
according to manufacturer’s instruction. To remove any contam-
inating genomic DNA, samples were treated with DNase
(TURBO DNA-freeTM, Ambion). Quantitative real-time PCR
analysis was performed as described below.
Primary Cell Culture and Stimulation
Three fish (1–1.5 kg) were anaesthetized with benzocaine, the
spleen was aseptically removed and placed in universal tubes
containing Leibowitz medium (L-15) containing 100 U/ml
penicillin, 100 mg/ml streptomycin, 0.5% FBS and 40 U/ml
heparin (referred herein as L-15i). The tissue was gently pushed
through sterile 100-mm mesh screens and the screens were rinsed
with L-15i. The resulting cell suspension was layered on 25/54%
Percoll gradient (GE Healthcare, Nydalen, Oslo, Norway) and
centrifuged at 4006g for 20 min at 4uC. Cells at the 25/54%
Percoll interface were collected, washed twice in L-15i by
centrifugation at 4006g for 10 min at 4uC, and the leukocytes
were then re-suspended in complete medium (the same as
incomplete medium but with 5% FBS) at 26106 cells/ml. One
millilitre of cells were seeded in 12 well tissue culture plates and
incubated at 14uC for 24, 48, and 72 h for each stimulant or
combination of stimulants. The leukocytes were stimulated with
known mitogens for T-cell stimulation i.e. PHA (10 mg/ml)+ConA
(10 mg/ml)+human IL-2 (1 ng/ml), and with recombinant Atlan-
tic salmon IFN-a2 at two dose levels: 5 ng/ml and 0.5 mg/ml.
Cloning of Eomesodermin cDNA and Transient
Transfection of Primary Spleen Lymphocytes
The N-terminal myc tagged full length AsEomes cDNA was
cloned into the XhoI and EcoRI site of the pcDNA3.1 expression
vector (Invitrogen).
Spleen leukocytes were transfected with 39modified Alexafluor
647Eomes-siRNA (small interfering RNA) and contol siRNA
(Qiagen, Hilden, Germany), Eomes/pcDNA3.1 vector or
pmaxGFP vector (Amaxa, Cologne, Germany), using the Human
T Cell Nucleofector Kit (Amaxa). After 4–5 h of nucleofection, the
leukocytes were stimulated with PHA (10 mg/ml)+ConA (10 mg/
ml)+human IL-2 (1 ng/ml) for 24 hours at 14uC. After trans-
fection, cells were analyzed by flow cytometry.
Flow Cytometry and RT-PCR of Sorted Cells
Following treatment of spleen leukocytes at different time
intervals, propidium iodide, (PI) (50 mg/ml) was added to each
1 ml cell suspension to stain dead cells. Fluorescence-activated cell
sorting was performed based on PI exclusion, forward scatter (FS),
and side scatter (SS) using BD FACSAriaTM Flow Cytometer (BD
Bioscience). Spleen lymphocytes were sorted based on their size.
Total RNA was isolated from 10,000 spleen lymphocytes using the
RNeasy Micro Kit (Qiagen, including DNase digestion). Purified
RNA was confirmed to be intact by gel electrophoresis while RNA
concentration and purity were measured spectrophotometrically
(Nano-Drop Technologies, Wilmington, USA). The synthesis of
cDNA was performed with Taqman RT Reagents (Applied
Biosystems, CA, USA) using random hexamers and 500 ng total
RNA as template in a 50 ml reaction volume.
Analysis of Gene Expression by Real-time PCR (QPCR)
QPCR was performed in duplicates with an ABI PRISM 7500
Fast Real-Time PCR System (Applied Biosystem) using Fast
SYBRH Green (Applied Biosystem). Reaction mixtures were
incubated for 10 min at 95uC, followed by 40 cycles of 15s at
95uC, 1 min at 60uC, and finally 15s at 95uC, 1 min 60uC, and
15 s at 95uC. For each mRNA, gene expression was normalized by
the EF-1a in each sample. The primers used are shown in Table1.
Immunofluorescence Analysis
Atlantic salmon spleen primary lymphocyte cells transfected
with siEomes and myc pcDNA3.1/Eomes plasmid were incubated
on poly-L-lysine coated coverslip and fixed with 4% para-
formaldehyde. Coverslips were incubated sequentially with 0.2%
Triton X-100 (Sigma), blocking buffer (PBS with 5% FBS),
primary antibodies [anti-zebrafish Eomes pAbs (1:1000 dilution)
and anti-myc monoclonal antibody (1:500 dilution) Covance,
Princeton, New Jersey] in blocking buffer, and fluorescent
secondary antibodies, Alexa Fluor 546 and 594 (Invitrogen) were
added at a 1:1000 dilution in the blocking buffer. The cells were
again washed three times with PBS and counter-stained with
DAPI (2 mg/ml) (Sigma), then mounted using anti-fading mount-
ing medium (DABCO). Confocal microscopy was performed using
a Leica TCS SP5 confocal microscope (Leica Microsystems
Gmbh, Mannheim, Germany) equipped with a 63X1.2 NA water
immersion objective. The excitation wavelengths for DAPI, Alexa
Fluor 546, and Alexa Fluor 594 were 405 nm, 561 nm, and
594 nm, respectively. The emission band passes were 450–
500 nm, 565–615 nm, and 600–630 nm, respectively. Live images
for studying positive transfection with si-Eomes RNA were
acquired using an LSM510 META laser scanning confocal
microscope (Carl Zeiss GmbH, Jena, Germany) equipped with
a 40X 1.2 NA water immersion objective. Alexa Fluor 647 was
excited using a 633 nm HeNe laser, and the emission band pass
was 644–719 nm.
Statistical Analysis
Data were analyzed by one-way analysis of variance (ANOVA)
followed by Tukey test using SPSS 19.0 software. Differences were
considered statistically significant when P,0.05.
Results
Sequencing and Characterization of Salmon
Eomesodermin
We identified the full-length cDNA sequence of Eomes
(GenBank accession number EU418014) from Atlantic salmon
by 59 and 39 RACE. The Atlantic salmon Eomes cDNA consisted
of 2477 bp in length including a 176 bp 59 untranslated region
(UTR), a 348 bp 39 UTR and possessed an open reading frame of
1953 bp. Four mRNA instability motifs (ATTTA) and one
polyadenylation signal (ATTAAA) were found followed by a poly
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(A) tail in the 39 UTR. The putative Eomes protein in Atlantic
salmon was predicted to be 650 aa with a molecular weight of
71 kDa and pI of 6.37. The conserved T-box DNA binding
domain consisted of 194 aa (Figure1).
Figure S1 shows the predicted aa sequences of salmon Eomes
and in other vertebrates. Salmon Eomes shared 79.3% and 58.2%
amino acid identity with zebrafish Eomes1 and human Eomes,
respectively (Table S1). Phylogenetic analysis showed that salmon
Eomes claded with zebrafish Eomes1 and was much closer to frog
and mammalian Eomes than to T-brain1 and T-bet of other
vertebrate species (Figure S2).
Structure of 59 Flanking Region of AsEomes Gene
As the first step towards understanding the transcriptional
regulation of the salmon Eomes gene, a sequence of 1,949 bp lying
59 to the TSS was determined (GenBank accession no. FJ360615).
Sequence analysis using the transcription factor binding site
prediction program MatInspector and TRANSFAC revealed
several notable features. Promoter analysis of the salmon Eomes
revealed the presence of important putative transcription binding
sites like SP1, Fork head domain factor (FOXO), Oct-1, SMAD,
STAT, Ets-1, FAST-1 SMAD interacting protein, and IRF 4 and
7 on the 59 flanking region of the salmon Eomes gene (Figure 2).
Furthermore, in the 59 flanking region of AsEomes, TATA box
was observed in the region close to the transcription initiation site
i.e. between nt 233 and 227 position upstream of transcription
start site (TSS). Lastly, CCAAT box was present at position nt
2127 which is also known to be important for transcriptional
regulation of genes in T cells. Other putative transcription factor-
binding sites are shown in Figure 2.
Functional Mapping of AsEomes Promoter
To analyse the promoter activity of the obtained 59 flanking
region of the AsEomes gene, the promoter-reporter plasmid
p(22003/+59) construct was transfected into the HeLa cell line
and the putative promoter driven luciferase activity was measured.
A 45-fold increase of luciferase activity (normalized to SEAP
activity) compared to promoter-less controls (pMetLuc-Reporter)
was obtained, indicating that the cloned 59-flanking region
represented the functional promoter of the AsEomes gene.
To precisely define the 59 end of TSS of salmon Eomes,
progressive deletion constructs of the AsEomes promoter region
were generated and transiently transfected into HeLa cells,
commonly used as host cells for transfection experiments, and
were subsequently stimulated with A. salmonicida LPS. These results
suggested that a basal core region responsible for the promoter
activity was located between nucleotide 2199 and 59, which
contained the TATA and CCAAT box. Reporter gene activity
observed in construct p(2518) showed no significant decrease
when the promoter sequence was extended to include an
additional 199 bp upstream when treated with LPS. Longer
promoter fragments p(21061 and 22003) exhibited a significant
decline of 50–60% in transcriptional activity compared to the
basal promoter construct p(2199) (P,0.05). This showed that the
LPS suppressive promoter activity was chiefly dependent on the
cis-elements located in the DNA region between 21061 and
22003 bp of the deletion construct (Figure 3). Thus, the pattern
suggests the presence of a negative regulatory element between
2518 and 21061 bp in the AsEomes promoter caused by LPS
stimulation.
Tissue Distribution of AsEomes Expression in Healthy
Salmon
As shown in Figure 4, AsEomes was expressed in all the tissues
sampled but strongly expressed in the ovary, spleen, brain, and the
head kidney, with the lowest expression level in the skin.
In vivo Regulation of AsEomes Expression
To elucidate the mechanism that regulates Eomes expression
in vivo and its modulation during bacterial and viral immune
Figure 1. Nucleotide and deduced amino acid sequence of
Atlantic salmon Eomes cDNA. Uppercase denotes the UTR’s and
lowercase denotes the coding regions. The T-box domain is underlined.
Start and stop codons are shaded and marked with bold letters. The
asterisk indicates the stop codon. The RNA instability motif (ATTTA) is
underlined. The putative polyadenylation signal is bold and underlined.
doi:10.1371/journal.pone.0055893.g001
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responses, we utilized challenge model based study with A.
salmonicida and IPN virus. We first examined the mRNA
expression levels of AsEomes, IFNc, CD8a, and granzyme A at
different time intervals following bacterial and viral infection in the
spleen and head kidney.
Figure 2. Atlantic salmon Eomes promoter sequence with consensus transcription factor binding sites. The consensus transcription
binding sites were predicted by MatInspector and TRANSFAC. Putative transcription factor binding sites are underlined, while (2) sign indicates the
binding sites identified on the negative strand. TATA box and transcription start site (+1) are shaded.
doi:10.1371/journal.pone.0055893.g002
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Following A. salmonicida infection, spleen AsEomes transcript
level was significantly higher at 48 h, and the level significantly
dropped on day 96 h post challenge. In the head kidney, there was
a slight increase till 24 h post challenge before the expression
decreased to a ‘‘resting’’ level at 48 h. CD8a expression in both
spleen and head kidney followed a similar time-dependent
expression pattern with an increase to 24 h followed by a decrease
at 96 h post challenge. The expression of the key genes for cell
mediated responses such as a granzyme A (CTL response) and
IFNc were significantly higher at 24 and 48 h post challenge
compared to controls, followed by a decreased expression at 96 h
in the spleen and in head kidney. The expressions in the head
kidney were delayed compared to the spleen. Statistical analysis
showed an overall strong correlation of Eomes expression with
CD8a and granzyme A, as well as between granzyme A and IFN-c
expressions post infection (Figure 5A).
During the cohabitation challenge experiment with IPNV, the
virus shedders started to die on day 6 post-challenge, whereas the
cohabitants started dying on day 19 post challenge. The gene
expression of granzyme A and IFNc increased significantly at 21
days post IPNV challenge. CD8a and Eomes showed similar
pattern of expression without any significant increase. The
expression of CD8a showed a strong correlation with Eomes,
IFNc and granzyme A, suggesting that they were interacting
(Figure 5B).
In vitro Regulated Expression in Spleen Lymphocytes
A bundle of stimulants, some of them known to activate
lymphocytes, were tested for their potency to regulate the
expression of Eomes and IFN-c in spleen lymphocytes isolated
by cell sorting. Interestingly, stimulation of spleen lymphocytes
with known T cell stimulants i.e. PHA+ConA and recombinant
huIL-2 resulted in the strongest and most significant induction of
Eomes expression upon 72 hours of incubation. Stimulation with
recombinant salmon IFN-a2 (0.5 mg/ml after 48 and 72 hours)
also induced significant higher expression of Eomes compared to
control cells (Figure 6A). Similar to expression of Eomes mRNA,
the IFN-c expression was also significantly increased after
stimulation with the mitogens, whereas rIFN-a2 (0.5 mg/ml)
induced IFN-c expression though not statistically significant
(Figure 6B).
To investigate Eomes-mediated induction on known CD8+ T
cell molecules, salmon lymphocytes were transfected with Eomes
cDNA expression vector. Transfection efficiency was found to be
Figure 3. Structural and functional analysis of the 59-upstream region of the salmon Eomes gene. HeLa cells were transiently transfected
with 0.3 mg of Eomes promoter/luciferase plasmid and 0.1 mg of Eomes promoter/SEAP plasmid (internal control). HeLa cells were stimulated with
LPS and after 24 h luciferase activities were measured. Units of luciferase activity were normalized to activity of cotransfected pSEAP (relative
luciferase activity). The error bars represent S.E.M values (n = 3). Asterisk (*) above the bars shows significant difference (P,0.05) compared to
respective control and the different letters (a and b) on the bars denote significant difference compared to the smallest construct. The bent arrow
represents the salmon Eomes transcriptional start site.
doi:10.1371/journal.pone.0055893.g003
Figure 4. Tissue distribution of Eomes expression in Atlantic
salmon. Expression of salmon Eomes in different organs as detected
by real-time PCR. Gene expression data were normalized to EF-1a
expression using skin as a calibrator. Bar represents the mean 6 S.E.M
(n = 6). Asterisk (*) above the bar shows significant difference (P,0.05)
compared with the organ that showed the lowest expression (skin). The
value above the bars shows average real-time CT values of six fish.
doi:10.1371/journal.pone.0055893.g004
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consistently greater than 50%. While over-expression of Eomes
up-regulated the expression of IFN-c and granzyme A (Figure 7A),
the expression of perforin remained undetectable in both Eomes
expressing cells and under silenced conditions (data not shown).
Furthermore, siRNA mediated silencing of Eomes expression in
the salmon lymphocytes led to abrogated expression of the
cytolytic gene granzyme A as well as of IFN-c but with slight
increase in T-box 21 expression (Figure 7B). Taken together, the
expression of the cytolytic gene granzyme A and the proin-
flammatory cytokine IFN-c in the salmon lymphocytes were
mainly controlled by Eomes. Moreover, silencing or augmenting
Eomes expression did not have significant effect on T-box 21 (T-
bet) expression in spleen lymphocytes.
We further analyzed the effects of Eomes-specific siRNA on
Eomes protein expression after 48 h of transfection in spleen cells
using immunostaining with anti-zebrafish Eomes antibody. Im-
munostaining was drastically reduced by the gene-specific siRNA
treatment compared to control siRNA-transfected cells showing
partial knockdown (Figure 8A). Similarly, in a transient ectopic
expression system using Eomes expression vector with myc-codon,
cells were positive for myc staining and the control expression
vector transfected cells were negative for myc staining (Figure 8B).
Figure 5. In vivo regulation of Eomes expression in Atlantic salmon post infection. (A) Tissue specific expression of granzyme A, IFN-c,
CD8a, and Eomes at different time-points after A. salmonicida challenge, and the overall correlation between them shown from top to bottom
respectively, in the left panel. (B) Tissue specific expression of granzyme A, IFN-c, CD8a, at different time-points after IPN virus challenge, and the
overall correlation between them including Eomes shown from top to bottom respectively, in the right panel (Eomes expression not shown since
there was no significant differences). Data were normalized to EF-1a expression at each time-points and presented as mean6 S.E.M (n = 6). Statistical
differences (P,0.05, P,0.01, and P,0.001) between different time-points compared to control are indicated by asterisk (*, **, and ***) respectively,
above the bars.
doi:10.1371/journal.pone.0055893.g005
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Discussion
In this study, we have proposed the presence of Eomes in
Atlantic salmon that possesses high degree of partial amino acid
homology to Eomes from other animal species. Especially, the
deduced amino acid sequence showed overall highest identity with
zebrafish Eomes1, while there were several identical residues in all
species that were aligned to AsEomes. This work presents new
knowledge on the regulated expression and function of Eomes in
lymphocytes of a lower vertebrate. We obtained the full-length
cDNA of Eomes and the normal tissue expression was analyzed.
AsEomes was strongly expressed in ovary which is in agreement
with the previous report on expression of Eomes in the oocytes of
zebrafish [5,15], and is in line with the moderate expression in
major lymphoid organs such as the spleen, and head kidney [15].
The expression in brain suggests its important role in neuronal
differentiation [21]. Furthermore, AsEomes transcript was highly
expressed after infection, which suggests its involvement in the
immune system of salmon.
Sequence analysis of 59 flanking region of AsEomes has revealed
that the presence of TATA box and CCAAT boxes in the
proximal promoter (2199 bp to the TSS) are in accordance with
the previous study on the Xenopus Eomes promoter [21]. More
recently, FOXO transcription factors were shown to bind to
a promoter site in the Eomes gene and to control its expression in
differentiated CD8+ T cells [22]. The presence of FOXO
transcription factor binding site in the promoter of AsEomes
may indicate similar underlying mechanisms of CD8 differentia-
tion in salmon as in mammals. By PCR-aided deletion of the
putative promoter region we detected a negative regulatory
element between positions 2518 and 21061 bp in the AsEomes
promoter following LPS stimulation. Further analysis of this
element indicated that they shared a number of consensus
transcription factor binding sites, including AP-1 and Oct-1 sites.
This could be consistent with the fact that Oct-1 and/or AP-1
function as repressors or enhancers depending on the context [23–
25]. Moreover, the promoter region containing the two AP-1 and
Oct-1 binding sites possessed the highest responsiveness to LPS
induction in terms of reporter gene activity. Together, these results
suggested that these two binding sites contributed to the LPS-
mediated AsEomes transcription in HeLa cells. It has been argued
that HeLa cells do not respond to LPS since they lack MD-2 that
cooperates with TLR4 [26]. The reason why this cell line
responded well to LPS in this study is not known. The LPS used in
this study is of approx. 90% purity, similar to commercial preps,
and may contain other cell activating substances. The functional
significance of these transcription factor-binding sites awaits
further investigation of the different transcriptional regulation of
the AsEomes gene.
In vivo post challenge studies showed acute simultaneous
expression of granzyme A and IFNc in both type of infections in
a tissue specific manner. These studies are consistent with the
hypothesis that differentiation of effector CD8+ T cells into
effector CTLs (as defined by cytotoxic activity) occurs subsequent
Figure 6. Regulators of Eomes expression in salmon lymphocytes. Spleen leukocytes were stimulated for 24 h, 48 h, and 72 h with
ConA+PHA+huIL-2, IFN-a (0.5 mg/ml, and 5 ng/ml), and the mRNA levels of Eomes (A), and IFN-c (B) were determined by real-time PCR. Gene
expression is normalized against EF-1a and is shown relative to the mean of the non-stimulated cells. Each bar represents the mean6 SE of triplicate
samples. Different letters denote statistically significant differences between the groups.
doi:10.1371/journal.pone.0055893.g006
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to, rather than during, the initial TCR stimulus. A strong
correlation between Eomes, CD8a, granzyme A and IFNc shows
an interaction between these genes and thus also appears to be
critical for invoking the characteristics of the cytolytic effector
lineage in salmon.
To delineate the mechanisms that regulate Eomes expression
in vitro, this study identified IFN-a, a known antiviral component
[27–29] and a known T-cell stimulator as an important inducer of
Eomes expression, which may in turn regulate the differentiation
of CD8+ T cells. In addition to the antiviral effects, IFN-a exerts
pleiotropic cellular effects, such as inhibition of cellular pro-
liferation, induction of apoptosis, and differentiation as well as
modulation of the immune system. The latter effect includes
inhibition of T-lymphocyte activation, enhancement of the
cytotoxic activity of NK cells and T lymphocytes [30].
Two T-box transcription factors, Eomes and T-bet, are
important for the development of effector and memory CTL
[3,10] as well as Th1 cells [31]. Studies using deletion,
overexpression or dominant negative analogues of these factors
have suggested that both of them are involved in the regulation
of expression of IFN-c, granzyme A and perforin [3,32].
Consistent with these data, except for perforin expression, the
results of partial knockdown, and ectopic overexpression of
Eomes has been shown to drive the expression of IFNc and
granzyme A, indicating that these genes are also direct targets
of AsEomes. However, overexpression of AsEomes was unable
to restore the perforin expression which is in line with the study
done in higher vertebrates indicating that Runx3 might be
required for Eomes to function at the Prf1 gene [33].
Nevertheless, silencing of AsEomes showed increase in T-box
21 expression that may depict a T-box21 dependent compen-
sation for Eomes for IFNc and granzyme A expression.
Therefore, the expression of the cytolytic gene granzyme A
and the proinflammatory cytokine IFN-c in fish lymphocytes
was controlled by Eomes, thus representing a similar function in
fish as to higher vertebrates. Further, to relate AsEomes
mediated regulatory effect on cytolytic activity similar to
mammals, in vitro cytotoxicity assay was included in our research
Figure 7. Eomes mediated effects on salmon spleen lymphocytes. Salmon leukocytes were transiently transfected with Eomes/pcDNA3.1
vector or control vector (pmaxGFP vector) (A) EomessiRNA or control siRNA (B). After 5 h, cells were stimulated with ConA+PHA+recombinant huIL-2.
24 h post stimulation, lymphocytes were sorted by FACS, collected and analyzed for the expression of Eomes, IFN-c, granzymeA, T-box21 and EF-1a
by QPCR. Eomes, IFN-c, granzymeA, T-box21 mRNA expression in cells transfected with control siRNA were set to 100%. Statistical differences
(P,0.005, and P,0.0004) between different treatment and control are indicated by asterisks (*, **) above the bars, respectively.
doi:10.1371/journal.pone.0055893.g007
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plan, but the lack of availability of effector cell donor fish and
target cells with identical classical MHC I alleles constrained
standardizing the in vitro T cell-mediated cytotoxicity assay with
MHC class I matched effector and target cells in Atlantic
salmon. As such, a ‘‘Atlantic salmon-specific’’ CD8+ T cell
mediated cytotoxicity assay was not performed. Allospecific
cytotoxic cells have been described in few fish species such as
ginbuna carp [34], channel catfish [35], and rainbow trout
[36,37]. Furthermore, recent studies using MHC class I
different/mismatched or xenogeneic target cells showed the
involvement of MHC independent innate cells (e.g. Natural
killer like cells) that mediated cytotoxicity instead of cytotoxic T-
cells [37]. Moreover, if bioactive recombinant salmon IFN-c
and antibodies to CD8, CD4, NK cells and resting and effector
CTLs etc. have been available a more targeted study on the
precise role of Eomes in salmon could have been performed.
To conclude, these data provide novel insights to better
understand the control mechanisms governing the functional
activity of T lymphocytes via Eomes in teleosts. Our data
suggested that the function of salmon Eomes is linked to expression
of IFN-c and cytolytic molecules, and that the expression of Eomes
can be modulated using IFN-a2. Our future efforts should be
aimed at determining how the two T-box transcription factors T-
bet and Eomes interplay in T cell differentiation and in the
resulting cytolytic functions, and also to identify the key
factors that induce the establishment of the a robust cytotoxi-
c, IFN-c secreting phenotype. This may constitute a novel ap-
proach to improve the understanding and maybe increase the
control of persistent infection in teleosts. This is imperative since
viral diseases are causing huge economic losses in the aquaculture
industry worldwide.
Figure 8. Immunofluorescence study following in vitro modulation of Eomes in Atlantic salmon. (A) siRNA knockdown of Eomes
expression (shown in pink) in spleen lymphocytes after 48 h. (B) Myc-labelled Eomes ectopic expression was detected with fluorescence labelling
(pink) using alexafluor 594. Nuclear staining was performed with DAPI (blue).
doi:10.1371/journal.pone.0055893.g008
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Supporting Information
Figure S1 Multiple alignment of Eomes in Atlantic
salmon with other vertebrates Eomes. Multiple alignment
of the deduced amino acid sequences of Eomes in salmon and
other vertebrates by the ClustalW2 program. Residues shaded in
black are completely conserved amino acids across all species
aligned, and residues shaded in grey refer to 80–90% identity.
Dashes indicate gaps. The T-box DNA binding domain is
indicated by solid line below the alignment. The GenBank
accession numbers of the Eomes sequences are as follows:
zebrafish, XP_571754; western clawed frog, NP_001122124;
African clawed frog, NP_001081810; mouse, NP_034266;
human, NP_005433.
(TIF)
Figure S2 Phylogenetic tree showing the relationship
between salmon Eomes and T-brain1 subfamily in other
vertebrates. The phylogram was constructed with the MEGA
4.0 software using the neighbour-joining method based on an
amino acid alignment (ClustalW) of the full-length protein.
Numbers beside the internal branches indicate bootstrap values
based on 10000 replications. The 0.05 scale indicates the genetic
distance. Accession numbers for Eomes are listed in the legend of
Fig. 2. The accession numbers of other T-brain1 subfamilies are as
follows: Zebrafish Eomes 2, T-brain1, and Tbet (NP_001077044,
NP_001108562, and XP_001338262), ginbuna T-bet
(BAF73805), frog Eomes and T-brain1(NP_001081810,
NP_001072587), Norway rat T-bet (NP_036896), mouse T-
brain1, and T-bet (NP_033348, and NP_062380), human T-
brain1, and T-bet (NP_006584, and NP_037483), Asterina T-
brain1 (BAA93701).
(TIF)
Table S1 Amino acid identity and similarity (%)
between different vertebrate Eomes.
(DOCX)
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